https://www.selleckchem.com/pr....oducts/crenolanib-cp
6%) of this ESUS population, 9 of these patients being AF positive (17.6% of the AF-positive patients) and 9 being AF negative (12.5% of AF-negative patients). Patients with AF were slightly older than patients without AF (63.1 ± 8.8 vs. 67.5 ± 9.6 years, = 0.12). Other parameters such as CHA DS -VASc score, infarct localization, micro- and macroangiopathy, carotid or aortic plaques, or stroke recurrence were not significantly different between groups. In ESUS patients, early implantation of an ILR with cardiac monitoring
Like
Comment
Share
